Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(84 sites)
United States
GSK Investigational Site, Phoenix, Arizona GSK Investigational Site, Jacksonville, Florida GSK Investigational Site, Orlando, Florida GSK Investigational Site, Iowa City, Iowa GSK Investigational Site, Overland Park, Kansas GSK Investigational Site, Boston, Massachusetts GSK Investigational Site, Boston, Massachusetts GSK Investigational Site, Rochester, Minnesota GSK Investigational Site, Omaha, Nebraska GSK Investigational Site, Lake Success, New York GSK Investigational Site, New York, New York GSK Investigational Site, Durham, North Carolina GSK Investigational Site, Philadelphia, Pennsylvania GSK Investigational Site, Philadelphia, Pennsylvania GSK Investigational Site, Knoxville, Tennessee GSK Investigational Site, Dallas, Texas GSK Investigational Site, Houston, Texas GSK Investigational Site, Tacoma, Washington Australia
GSK Investigational Site, Melbourne, Victoria Belgium
GSK Investigational Site, Leuven Brazil
GSK Investigational Site, Barretos, São Paulo GSK Investigational Site, Porto Alegre GSK Investigational Site, Recife GSK Investigational Site, Vitória Canada
GSK Investigational Site, Toronto, Ontario GSK Investigational Site, Montreal, Quebec China
GSK Investigational Site, Beijing GSK Investigational Site, Jinan France
GSK Investigational Site, Bordeaux GSK Investigational Site, Lille GSK Investigational Site, Lyon GSK Investigational Site, Saint-Herblain GSK Investigational Site, Villejuif Germany
GSK Investigational Site, Berlin Italy
GSK Investigational Site, Meldola, FC GSK Investigational Site, Candiolo GSK Investigational Site, Milan GSK Investigational Site, Palermo GSK Investigational Site, Roma Japan
GSK Investigational Site, Chiba GSK Investigational Site, Ehime GSK Investigational Site, Fukuoka GSK Investigational Site, Hokkaido GSK Investigational Site, Kanagawa GSK Investigational Site, Kumamoto GSK Investigational Site, Miyagi GSK Investigational Site, Osaka GSK Investigational Site, Tokyo GSK Investigational Site, Tokyo Netherlands
GSK Investigational Site, Nijmegen Norway
GSK Investigational Site, Oslo Poland
GSK Investigational Site, Kielce GSK Investigational Site, Poznan GSK Investigational Site, Warsaw Romania
GSK Investigational Site, Bucharest GSK Investigational Site, Craiova GSK Investigational Site, Timișoara South Korea
GSK Investigational Site, Daegu GSK Investigational Site, Seongnam-si Gyeonggi-do GSK Investigational Site, Seoul GSK Investigational Site, Seoul GSK Investigational Site, Seoul GSK Investigational Site, Seoul GSK Investigational Site, Suwon Kyunggi-do GSK Investigational Site, Yangsan Spain
GSK Investigational Site, Barcelona GSK Investigational Site, Madrid GSK Investigational Site, Madrid GSK Investigational Site, Madrid GSK Investigational Site, Oviedo GSK Investigational Site, Seville GSK Investigational Site, Valencia GSK Investigational Site, Zaragoza Taiwan
GSK Investigational Site, Changhua GSK Investigational Site, Kaohsiung City GSK Investigational Site, Kaohsiung City GSK Investigational Site, Taipei GSK Investigational Site, Taipei GSK Investigational Site, Taoyuan District United Kingdom
GSK Investigational Site, Cambridge GSK Investigational Site, London GSK Investigational Site, London GSK Investigational Site, Manchester GSK Investigational Site, Sheffield